The American Journal of Medicine
Volume 122, Issue 4 , Pages 356-365 , April 2009

Long-Acting Calcium Antagonists in Patients with Coronary Artery Disease: A Meta-Analysis

This work was presented in part at the Annual Scientific Session of the American College of Cardiology, New Orleans, Louisiana, 2007.

  • Sripal Bangalore, MD, MHA
    • ,
  • Sanobar Parkar, MD, MPH
    • ,
  • Franz H. Messerli, MD

      Affiliations

    • Corresponding Author InformationRequests for reprints should be addressed to Franz H. Messerli, MD, Director, Hypertension Program, Division of Cardiology, St. Luke's-Roosevelt Hospital, 1000 10th Avenue, Suite 3B-30, New York, NY 10019

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Funding: None.

 Conflicts of Interest: Sripal Bangalore: no disclosures; Sanobar Parkar: no disclosures; Franz H Messerli: Speakers' Bureau—Abbott, GlaxoSmithKline, Novartis, Pfizer, AstraZeneca, Bayer, Boehringer Ingelheim, BMS, Forest, Sankyo, Sanofi. Research/Grants—GlaxoSmithKline, Pfizer, Novartis, CardioVascular Therapeutics.

 Authorship: All authors had access to the data and had a role in writing the manuscript.

PII: S0002-9343(08)01104-2

doi: 10.1016/j.amjmed.2008.09.043

The American Journal of Medicine
Volume 122, Issue 4 , Pages 356-365 , April 2009

Article Tools

* Image Usage & Resolution